Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-021181
Filing Date
2021-04-12
Accepted
2021-04-12 16:05:34
Documents
3
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea139206-def14a_citiuspharma.htm DEF 14A 298778
2 GRAPHIC proxy_001.jpg GRAPHIC 396910
3 GRAPHIC proxy_002.jpg GRAPHIC 221380
  Complete submission text file 0001213900-21-021181.txt   1151545
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 21820779
SIC: 2834 Pharmaceutical Preparations